InnovaDerma PLC Directorate Change (2022V)
August 05 2020 - 4:15AM
UK Regulatory
TIDMIDP
RNS Number : 2022V
InnovaDerma PLC
05 August 2020
LEI: 213800WRAP6W8VDL6B38
InnovaDerma PLC
("InnovaDerma" or the "Group")
Directorate Changes
InnovaDerma (LSE: IDP), a UK developer of beauty, personal care
and life science products, today announces that Kieran Callan has
stepped down as Chief Executive Officer and as a Director of the
Group with immediate effect, by mutual agreement with the Board.
Kieran will continue to be available until 31 August 2020 for any
handover and to assist the Board in any relevant matters.
The Group has commenced a formal process for the identification
and appointment of a new CEO and will provide updates, as
appropriate, in due course. In the meantime, Joe Bayer will serve
as Interim CEO as well as Executive Chairman.
In addition, InnovaDerma announces that Warren Dockary,
currently Group Financial Controller has been appointed as Chief
Financial Officer and will report to the Board. Warren is a
Chartered Accountant and has been with the business since November
2018. He is a graduate from Massey University in New Zealand and
has held senior finance roles in the consumer products and
logistics industries.
On behalf of the Board, Executive Chairman and Interim CEO, Joe
Bayer said :
"The Board and I would like to thank Kieran for his contribution
and strategic insight over the past three years, first as a
Non-executive Director then as a CEO when he was appointed in 2018.
InnovaDerma is a strong business with a clear strategy, underpinned
by a multi-channel approach with ecommerce being the most important
factor for future growth. We have agreed that now is the right time
for a change of leadership in the Group to implement that strategy
and maximise the opportunities that lie ahead.
"We are pleased to have appointed Warren to the role of Chief
Financial Officer, and it is particularly pleasing to make this
very well-deserved promotion from within the business. Warren has
deep knowledge of the business and his appointment strengthens our
senior management team."
Kieran Callan, outgoing CEO, said:
"It is a privilege to have worked at InnovaDerma and I leave
behind an immensely talented team and a business which is resilient
and delivering upon its strategic aims. We have developed our
customer-centric and digital-led strategy that will guide the
future of the business over the coming years and I feel it is the
right time to step down and seek new challenges elsewhere. The
Company is strongly positioned and I look forward to see it going
from strength to strength."
This announcement contains inside information for the purposes
of Article 7 of EU Regulation 596/2014.
Further enquiries
InnovaDerma
Joe Bayer +61 417 870 743
finnCap Ltd
Geoff Nash/Kate Bannatyne +44 (0)207 220 0500
Alice Lane/Manasa Patil - Corporate www.finncap.com
Broking
---------------------------
TB Cardew
Shan Shan Willenbrock/Tom Allison + 44 (0)20 7930 0777
Olivia Rosser innovaDerma@tbcardew.com
---------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BOASSFSAIESSEFA
(END) Dow Jones Newswires
August 05, 2020 04:15 ET (08:15 GMT)
Innovaderma (LSE:IDP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Innovaderma (LSE:IDP)
Historical Stock Chart
From Apr 2023 to Apr 2024